Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Genetic mutations can affect female sexual development, requiring personalized medical care.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Feminizing hormone therapy increases kidney filtration rate.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Antiandrogens block male hormones and are not safe during pregnancy.